|
Name |
3aalpha-Hydroxy-5abeta-methyl-6beta-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-3a,4,5,5a,6,7,8,8aalpha-octahydro-2H-indeno[5,4-b]furan-2-one
|
Molecular Formula | C21H32O3 | |
IUPAC Name* |
(3aS,5aR,6R,8aR)-6-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-3a-hydroxy-5a-methyl-4,5,6,7,8,8a-hexahydrocyclopenta[e][1]benzofuran-2-one
|
|
SMILES |
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@]3(C2=CC(=O)O3)O)C
|
|
InChI |
InChI=1S/C21H32O3/c1-13(2)14(3)6-7-15(4)16-8-9-17-18-12-19(22)24-21(18,23)11-10-20(16,17)5/h6-7,12-17,23H,8-11H2,1-5H3/b7-6+/t14-,15+,16+,17-,20+,21-/m0/s1
|
|
InChIKey |
UINDYEKBRZRPSX-QPLMFNHESA-N
|
|
Synonyms |
Demethylincisterol A3; (3aS,5aR,6R,8aR)-3a-Hydroxy-5a-methyl-6-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen- 1-yl]-3a,4,5,5a,6,7,8,8a-octahydro-2H-cyclopenta[e]benzofuran-2-one; 3aalpha-Hydroxy-5abeta-methyl-6beta-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-3a,4,5,5a,6,7,8,8aalpha-octahydro-2H-indeno[5,4-b]furan-2-one; 3aalpha-Hydroxy-5abeta-methyl-6beta-[(1R,4R)-1,4,5-trimethyl-2-hexenyl]-3a,4,5,5a,6,7,8,8aalpha-octahydro-2H-indeno[5,4-b]furan-2-one
|
|
CAS | NA | |
PubChem CID | 15215298 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 332.5 | ALogp: | 4.6 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 3 |
Heavy Atoms: | 24 | QED Weighted: | 0.584 |
Caco-2 Permeability: | -4.649 | MDCK Permeability: | 0.00002840 |
Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.142 |
Blood-Brain-Barrier Penetration (BBB): | 0.089 | Plasma Protein Binding (PPB): | 84.32% |
Volume Distribution (VD): | 1.141 | Fu: | 2.11% |
CYP1A2-inhibitor: | 0.053 | CYP1A2-substrate: | 0.352 |
CYP2C19-inhibitor: | 0.135 | CYP2C19-substrate: | 0.918 |
CYP2C9-inhibitor: | 0.266 | CYP2C9-substrate: | 0.084 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.086 |
CYP3A4-inhibitor: | 0.75 | CYP3A4-substrate: | 0.922 |
Clearance (CL): | 5.629 | Half-life (T1/2): | 0.106 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.138 |
Drug-inuced Liver Injury (DILI): | 0.368 | AMES Toxicity: | 0.075 |
Rat Oral Acute Toxicity: | 0.875 | Maximum Recommended Daily Dose: | 0.899 |
Skin Sensitization: | 0.522 | Carcinogencity: | 0.037 |
Eye Corrosion: | 0.091 | Eye Irritation: | 0.453 |
Respiratory Toxicity: | 0.678 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004677 | 1.000 | D06JPB | 0.450 | ||||
ENC002957 | 0.760 | D0G8OC | 0.450 | ||||
ENC005610 | 0.573 | D0G5CF | 0.441 | ||||
ENC004864 | 0.573 | D0N1TP | 0.336 | ||||
ENC006035 | 0.573 | D08SVH | 0.289 | ||||
ENC006033 | 0.531 | D01QUS | 0.287 | ||||
ENC003120 | 0.531 | D0K5WS | 0.277 | ||||
ENC004906 | 0.531 | D0Y7LD | 0.265 | ||||
ENC002665 | 0.526 | D02ZGI | 0.246 | ||||
ENC006032 | 0.519 | D0I2SD | 0.243 |